180 related articles for article (PubMed ID: 15158969)
41. Polymer conjugated bovine seminal ribonuclease inhibits growth of solid tumors and development of metastases in mice.
Soucek J; Poucková P; Zadinová M; Hlousková D; Plocová D; Strohalm J; Hrkal Z; Oleár T; Ulbrich K
Neoplasma; 2001; 48(2):127-32. PubMed ID: 11478693
[TBL] [Abstract][Full Text] [Related]
42. Doxorubicin loaded pH-sensitive polymeric micelles for reversal of resistant MCF-7 tumor.
Lee ES; Na K; Bae YH
J Control Release; 2005 Mar; 103(2):405-18. PubMed ID: 15763623
[TBL] [Abstract][Full Text] [Related]
43. Schedule-dependent interaction between Doxorubicin and mTHPC-mediated photodynamic therapy in murine hepatoma in vitro and in vivo.
Kirveliene V; Grazeliene G; Dabkeviciene D; Micke I; Kirvelis D; Juodka B; Didziapetriene J
Cancer Chemother Pharmacol; 2006 Jan; 57(1):65-72. PubMed ID: 16001168
[TBL] [Abstract][Full Text] [Related]
44. Preclinical evaluation of linear HPMA-doxorubicin conjugates with pH-sensitive drug release: efficacy, safety, and immunomodulating activity in murine model.
Sirova M; Mrkvan T; Etrych T; Chytil P; Rossmann P; Ibrahimova M; Kovar L; Ulbrich K; Rihova B
Pharm Res; 2010 Jan; 27(1):200-8. PubMed ID: 19894105
[TBL] [Abstract][Full Text] [Related]
45. The same drug but a different mechanism of action: comparison of free doxorubicin with two different N-(2-hydroxypropyl)methacrylamide copolymer-bound doxorubicin conjugates in EL-4 cancer cell line.
Kovár L; Strohalm J; Chytil P; Mrkvan T; Kovár M; Hovorka O; Ulbrich K; Ríhová B
Bioconjug Chem; 2007; 18(3):894-902. PubMed ID: 17402705
[TBL] [Abstract][Full Text] [Related]
46. Development of zwitterionic polymer-based doxorubicin conjugates: tuning the surface charge to prolong the circulation and reduce toxicity.
Wang Z; Ma G; Zhang J; Lin W; Ji F; Bernards MT; Chen S
Langmuir; 2014 Apr; 30(13):3764-74. PubMed ID: 24617705
[TBL] [Abstract][Full Text] [Related]
47. Optimization of (1,2-diamino-cyclohexane)platinum(II)-loaded polymeric micelles directed to improved tumor targeting and enhanced antitumor activity.
Cabral H; Nishiyama N; Kataoka K
J Control Release; 2007 Aug; 121(3):146-55. PubMed ID: 17628162
[TBL] [Abstract][Full Text] [Related]
48. Increased effects of MPDAX, a novel xanthine derivative, on antitumor activity of doxorubicin.
Sadzuka Y; Sugiyama T; Suzuki H; Sawanishi H; Miyamoto K
Toxicol Lett; 2004 May; 150(3):341-9. PubMed ID: 15110086
[TBL] [Abstract][Full Text] [Related]
49. A mechanistic study of enhanced doxorubicin uptake and retention in multidrug resistant breast cancer cells using a polymer-lipid hybrid nanoparticle system.
Wong HL; Bendayan R; Rauth AM; Xue HY; Babakhanian K; Wu XY
J Pharmacol Exp Ther; 2006 Jun; 317(3):1372-81. PubMed ID: 16547167
[TBL] [Abstract][Full Text] [Related]
50. Tumor targeting by doxorubicin-RGD-4C peptide conjugate in an orthotopic mouse hepatoma model.
Kim JW; Lee HS
Int J Mol Med; 2004 Oct; 14(4):529-35. PubMed ID: 15375578
[TBL] [Abstract][Full Text] [Related]
51. Fluoxetine inhibits multidrug resistance extrusion pumps and enhances responses to chemotherapy in syngeneic and in human xenograft mouse tumor models.
Peer D; Dekel Y; Melikhov D; Margalit R
Cancer Res; 2004 Oct; 64(20):7562-9. PubMed ID: 15492283
[TBL] [Abstract][Full Text] [Related]
52. New HPMA copolymer-based drug carriers with covalently bound hydrophobic substituents for solid tumour targeting.
Chytil P; Etrych T; Konák C; Sírová M; Mrkvan T; Boucek J; Ríhová B; Ulbrich K
J Control Release; 2008 Apr; 127(2):121-30. PubMed ID: 18304673
[TBL] [Abstract][Full Text] [Related]
53. Enhanced circulation time and antitumor activity of doxorubicin by comblike polymer-incorporated liposomes.
Han HD; Lee A; Hwang T; Song CK; Seong H; Hyun J; Shin BC
J Control Release; 2007 Jul; 120(3):161-8. PubMed ID: 17524514
[TBL] [Abstract][Full Text] [Related]
54. Preparation and biological characterization of polymeric micelle drug carriers with intracellular pH-triggered drug release property: tumor permeability, controlled subcellular drug distribution, and enhanced in vivo antitumor efficacy.
Bae Y; Nishiyama N; Fukushima S; Koyama H; Yasuhiro M; Kataoka K
Bioconjug Chem; 2005; 16(1):122-30. PubMed ID: 15656583
[TBL] [Abstract][Full Text] [Related]
55. Development of elastin-like polypeptide for thermally targeted delivery of doxorubicin.
Bidwell GL; Fokt I; Priebe W; Raucher D
Biochem Pharmacol; 2007 Mar; 73(5):620-31. PubMed ID: 17161827
[TBL] [Abstract][Full Text] [Related]
56. Tumoral acidic extracellular pH targeting of pH-responsive MPEG-poly(beta-amino ester) block copolymer micelles for cancer therapy.
Ko J; Park K; Kim YS; Kim MS; Han JK; Kim K; Park RW; Kim IS; Song HK; Lee DS; Kwon IC
J Control Release; 2007 Nov; 123(2):109-15. PubMed ID: 17894942
[TBL] [Abstract][Full Text] [Related]
57. Biodistribution of doxorubicin-alkylated poly(L-lysine citramide imide) conjugates in an experimental model of peritoneal carcinomatosis after intraperitoneal administration.
Colombo PE; Boustta M; Poujol S; Pinguet F; Rouanet P; Bressolle F; Vert M
Eur J Pharm Sci; 2007 May; 31(1):43-52. PubMed ID: 17383164
[TBL] [Abstract][Full Text] [Related]
58. Fullerene-conjugated doxorubicin in cells.
Liu JH; Cao L; Luo PG; Yang ST; Lu F; Wang H; Meziani MJ; Haque SA; Liu Y; Lacher S; Sun YP
ACS Appl Mater Interfaces; 2010 May; 2(5):1384-9. PubMed ID: 20420365
[TBL] [Abstract][Full Text] [Related]
59. Biodegradable and amphiphilic block copolymer-doxorubicin conjugate as polymeric nanoscale drug delivery vehicle for breast cancer therapy.
Yang Y; Pan D; Luo K; Li L; Gu Z
Biomaterials; 2013 Nov; 34(33):8430-43. PubMed ID: 23896006
[TBL] [Abstract][Full Text] [Related]
60. Antitumor activity of adriamycin-incorporated polymeric micelles of poly(gamma-benzyl L-glutamate)/poly(ethylene oxide).
Jeong YI; Na HS; Cho KO; Lee HC; Nah JW; Cho CS
Int J Pharm; 2009 Jan; 365(1-2):150-6. PubMed ID: 18786625
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
